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Background: The aim of the study was to assess the use of the Nijmegen Clinical Screening Instrument (NCSI) and
Short Form 36 (SF-36) in providing a detailed assessment of health status of Q-fever patients and to evaluate which
subdomains within the NCSI and SF-36 measure unique aspects of health status.
Findings: Patients received a study questionnaire, which contained the NCSI and SF-36. Pearson correlation
coefficients between subdomains of the instruments were calculated. The response rate was 94% (309 out of 330
eligible patients). Intercorrelations between subdomains of the NCSI were generally lower than of the SF-36. Four
subdomains of the NCSI showed conceptual similarity (Pearson’s r ≥ .70) with one or more subdomains of the SF-36
and vice versa. Subdomains that showed no conceptual similarity were NCSI Subjective Pulmonary Symptoms,
Subjective Impairment, Dyspnoea Emotions and Satisfaction Relations, and SF-36 Social functioning, Bodily Pain,
Role Physical and Role Emotional.
Conclusions: Our results show that either the NCSI or SF-36 can be used to measure health status in Q-fever
patients. When the aim is to obtain a detailed overview of the patients’ health, a combination of the two
instruments, consisting of the complete NCSI and the four unique subdomains of the SF-36, is preferred.
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Introduction
Q-fever is a zoonotic illness caused by the intracellular
bacterium Coxiella burnetii. The disease was relatively
uncommon in the Netherlands until 2007 and only known
as an occupational illness, mainly affecting farmers, veteri-
narians and laboratory workers. Between 2007 and 2011,
the Netherlands experienced the largest Q-fever outbreak
ever reported (a total of 4108 acute notified Q-fever pa-
tients) [1]. Approximately 40% of all persons infected
with Q-fever develop symptoms such as fever, pneumo-
nia and hepatitis [2,3], but there remains a poor
description of disease progression. We have established
a detailed prospective cohort study to assesses the* Correspondence: j.vanloenhout@elg.umcn.nl
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distribution, and reproduction in any mediumshort- and long-term clinical progression of Q-fever
over time [4].
Several studies have shown that a relatively large group
of patients suffer from persistent fatigue and long-lasting
symptoms after acute Q-fever [5-11]. Of seven published
studies, two in the Netherlands used the Nijmegen Clin-
ical Screening Instrument (NCSI) [10,11], one in Canada
used the Short Form 36 (SF-36) [5] and the remaining
studies used other instruments to measure health status
of Q-fever patients. In the Netherlands, studies that fo-
cused on the long-term effects on health status have
shown that around 50% of patients suffered from severe
fatigue at least one year after onset of illness [10,11].
Patients with Q-fever experience not only severe fa-
tigue but also many other health problems, such as
dyspnoea, anxiety and frustration with dyspnoea, func-
tional impairments in daily life, and an impaired quality
of life [10,11]. This means that in order to understandCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
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patients with Q-fever, an instrument that provides a
detailed picture of many different aspects of patients’
health status is required.
There are eight subdomains in both the NCSI and SF-
36 and these measure eight aspects of health status
(Table 1) [12,13]. Until now it has never been investi-
gated whether both instruments measure the same as-
pects of health status or whether they complement each
other when assessing the health impact of Q-fever on pa-
tients. The main aim of our study was to identify an instru-
ment - or a combination of instruments - that would
provide a detailed assessment of health status of Q-fever
patients. We assessed whether subdomains within each in-
strument measure unique aspects of health status, or
whether there is conceptual similarity between subdomains
of the NCSI and SF-36. This was done by calculating inter-
correlations (overlap within instruments) as well as correla-
tions (overlap between instruments). The results will yield
important information for future studies on how to meas-
ure health status of Q-fever patients.
Methods
Patients diagnosed with Q-fever in 2010 and 2011 who
were at least 18 years of age and fulfilled the DutchTable 1 Domains, subdomains and number of questions
for both the NCSI and SF-36
Instrument Domain Subdomain Number of
questions


























Mental health Vitality 4
Social functioning 2
Role emotional 3
Mental health 5notification criteria for Q-fever were eligible for this
study [14]. Patients received a consent form and the
study questionnaire by postal mail and those who did
not respond received a reminder by telephone or postal
mail. The study questionnaire consisted of the NCSI and
SF-36, but it also collected socio-demographic and clin-
ical information. The current study uses patients’ infor-
mation at 12 months after onset of illness [4].
The NCSI was originally developed to provide a de-
tailed assessment of health status of COPD patients and
has been available since 2009 in English, German and
Dutch. It combines a number of existing health status
questionnaires [12]. The SF-36 was developed in 1988,
aims to assess the quality of life of patients and is avail-
able in over 170 languages [13].
The relationships between the subdomains of the
NCSI and SF-36 were calculated using Pearson correl-
ation coefficients. A Pearson’s r ≥ .70 was used as criter-
ion for conceptual similarity [15]. A Pearson’s r < .30
indicates no meaningful correlation.
Results
Questionnaires were returned by 309 out of 330 patients
(response rate 94%). The mean age of the study group
was 49.9 (SD 13.8) and 53.7% was male. There was a sta-
tistically significant difference in age between responders
and non-responders (49.9 vs. 43.1 respectively); other
characteristics (gender, nationality, educational level,
BMI, smoking behaviour, alcohol consumption) were not
significantly different (data not shown).
Intercorrelations between the subdomains of the NCSI
and SF-36 are presented in Table 2. In general, the NCSI
shows lower intercorrelations between the subdomains
than the SF-36. The proportion of intercorrelations ≤ .60
was 79% for the NCSI and 36% for the SF-36. Intercorrela-
tions ≥ .70, indicating conceptual similarity, are found four
times for the NCSI and three times for SF-36. In the
NCSI, conceptual similarity is found between the sub-
domains Subjective Pulmonary Symptoms, Subjective Im-
pairment and Dyspnoea Emotions, and between Fatigue
and Health-Related Quality of Life. In the SF-36, concep-
tual similarity is found between Vitality on the one hand
and General Health, Mental Health and Social Function-
ing on the other hand.
Correlations between the subdomains of the NCSI
versus the SF-36 are presented in Table 3. All correla-
tions were statistically significant (p < .01). NCSI Fatigue
reached the criterion for conceptual similarity with SF-
36 Vitality and General Health. NCSI Behavioural Im-
pairment is shown to be conceptually similar to SF-36
Physical Functioning. NCSI General Quality of Life is
conceptually similar to SF-36 Mental Health, and NCSI
Health-Related Quality of Life is conceptually similar to
SF-36 General Health and Vitality.


















1 .70 .53 .49 .81 .36 .47 .38
Dyspnoea emotions 1 .50 .45 .70 .48 .50 .37
Fatigue 1 .53 .57 .50 .74 .42
Behavioural impairment 1 .59 .37 .57 .40
Subjective impairment 1 .45 .59 .42



















Physical functioning 1 .65 .63 .64 .63 .63 .48 .47
Role physical 1 .58 .62 .69 .66 .60 .50
Bodily pain 1 .61 .61 .58 .39 .42
General health 1 .76 .63 .46 .55
Vitality 1 .75 .54 .72
Social functioning 1 .67 .69
Role emotional 1 .66
Mental health 1
Pearson’s intercorrelations for the Nijmegen Clinical Screening Instrument (NCSI) and Short Form 36 (SF-36) for Q-fever patients at 12 months after onset of illness.
N = 3091, p < .01 for all intercorrelations. Intercorrelations ≥ .70 are in italics.
1) N varies between 302 and 309 for individual intercorrelations, due to missing values within some of the questionnaires.
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The main aim of our study was to identify an instrument
or a combination of instruments that would provide a
detailed assessment of health status of patients with Q-
fever. We investigated whether there is conceptual simi-
larity between the subdomains of the instruments NCSI
and SF-36 or whether both instruments are complemen-






Subjective pulmonary symptoms .53 .43
Dyspnoea emotions .50 .51
Fatigue .59 .68
Behavioural impairment .71 .60
Subjective impairment .63 .54
General quality of life .45 .49
Health-related quality of life .61 .64
Satisfaction relations .40 .43
Pearson’s correlations between subdomains of the Nijmegen Clinical Screening Inst
after onset of illness. N = 3091, p < .01 for all correlations. Correlations ≥ .70 are in it
1) N varies between 302 and 309 for individual correlations, due to missing valuesThe NCSI shows lower intercorrelations between the
subdomains than the SF-36, indicating that the NCSI
subdomains represent independent concepts to a higher
degree. Some intercorrelations were very high where we
did not expect this, such as between SF-36 Vitality
(measuring fatigue, as indicated by the very high correl-
ation with NCSI Fatigue) and SF-36 General Health,











.46 .53 .50 .51 .46 .40
.46 .52 .50 .57 .53 .52
.61 .72 .85 .63 .47 .54
.51 .54 .58 .58 .44 .40
.53 .59 .58 .59 .48 .45
.43 .53 .63 .59 .52 .76
.58 .71 .77 .66 .54 .66
.36 .46 .56 .58 .49 .60
rument (NCSI) and Short Form 36 (SF-36) for Q-fever patients at 12 months
alics.
within some of the questionnaires.
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showed conceptual similarity with NCSI Health-Related
Quality of Life. A possible explanation for these high
intercorrelations is that fatigue is the most dominant
symptom of Q-fever patients and dominates the wellbeing
of the patients as expressed by other subdomains. Previ-
ous studies have already shown that Fatigue and General
Quality of Life are the NCSI subdomains most severely
affected in Q-fever patients at 12 months after onset of
illness [10,11].
Several subdomains measure concepts of health status
not measured by the other instrument. These are: NCSI
Subjective Pulmonary Symptoms, Subjective Impairment,
Dyspnoea Emotions and Satisfaction Relations; SF-36 So-
cial functioning, Bodily Pain, Role Physical and Role
Emotional. This means that if one wants to assess these
specific subdomains, one needs to use either the NCSI or
SF-36.
Conceptual similarity was found between four sub-
domains of each instrument, which implies that these
subdomains of both instruments measure the same
aspects of health status. The highest correlations were
found between SF-36 Vitality and NCSI Fatigue and
Health-Related Quality of Life (Pearson’s r of .84 and .77
respectively). There is conceptual similarity between
NCSI Fatigue and both SF-36 General Health and Vital-
ity, and between NCSI General Quality of Life and SF-
36 Mental Health. This implies that both the NCSI and
SF-36 can be used to evaluate the aspects of health sta-
tus that are the most affected in Q-fever patients [10,11].
Advantages of the SF-36 are its length (only 36 questions
compared to 56 in the NCSI) and the fact that it is
publically available in more than 170 languages, due to
which it is more often used in international studies,
which makes it possible to compare the health impact of
Q-fever to other diseases. The results also show that the
Dutch studies which used the NCSI can be compared to
international studies that used SF-36 in Q-fever patients
[5]. Advantages of the NCSI are that the concepts of
health status it measures are more unique and it allows
a description of health status on the level of the individ-
ual (as a normal, mild or severe score is available for
each subdomain).
Conclusions
When measuring the general health status of Q-fever
patients, our study shows that either the NCSI or the
SF-36 can be used. Only if the aim is to obtain a detailed
overview of patients’ health status, we advise that both
the NCSI and SF-36, or at minimum a combination of
the two, should be used. When combining the instru-
ments we recommend that the NCSI is used (since it
measures more variation in aspects of health status and
because of the normative data) and it is complementedwith the SF-36 subdomains not covered by the NCSI (i.
e. SF-36 Role Physical, Bodily Pain, Social Functioning,
Role Emotional). When the aim is to formulate a patient-
centered intervention, the NCSI is preferred as it covers
the important health status subdomains and since it pro-
vides a description of clinically relevant scores (normal,
mild, severe) on an individual level.
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